In the US, Catapres (clonidine systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat Alcohol Withdrawal, Anxiety, Atrial Fibrillation, Benzodiazepine Withdrawal, Bipolar Disorder, High Blood Pressure, Hyperhidrosis, Hypertensive Emergency, Insomnia - Stimulant-Associated, Migraine Prevention, Opiate Withdrawal, Pain, Perimenopausal Symptoms, Pheochromocytoma Diagnosis, Postherpetic Neuralgia, Restless Legs Syndrome, Tourette's Syndrome and Ulcerative Colitis.
- Catapres-TTS patches
- Catapres-TTS-1 Transdermal
- Catapres-TTS-2 Transdermal
- Catapres-TTS-3 Transdermal
Ingredient matches for Catapres
Clonidine is reported as an ingredient of Catapres in the following countries:
- New Zealand
Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Catapres in the following countries:
- New Zealand
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.